Global Radiofrequency Ablation for Cardiology Market report provides a holistic assessment of the worldwide and regional market for the forecast period (2022-2030). The report includes various ...

The study conducted across multiple high-volume cardiac centers in the United States, demonstrated that 81.6% of patients were free from AFib symptoms one year after undergoing RF ablation.

Vancouver, Jan. 04, 2024 (GLOBE NEWSWIRE) -- The global Radiofrequency Ablation (RFA) devices market size was USD 4.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.0% ...

Stereotaxis announced that it entered into definitive agreements with investors to sell approximately $12.5 million in common stock.

Stereotaxis STXS recently announced the publication of initial clinical results from its MAGiC catheter in the Journal of ...

Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique ...

CRABL-HF trial finds cryoballoon (CB) ablation is as safe and effective as radiofrequency (RF) ablation for correcting the root cause of atrial fibrillation (AF) in heart failure patients with a ...

Collateral effects on non-target tissue are worse with pulsed-field ablation than with radiofrequency ablation, according to a study published April 24 in JACC: Clinical Electrophysiology.. The ...

HANGZHOU, China, March 4, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF ...

Covina, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Fluid-cooled radiofrequency (RF) ablation is an advanced medical procedure used to treat various medical conditions, particularly in the field of ...